| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/06/2007 | US20070281968 Compounds Derived From Artesunate, Preparation Process, Pharmaceutical Composition And Use Of The Respective Medicine |
| 12/06/2007 | US20070281967 Nuclear Transfer Promoter For Rac Protein And Method Of Screening The Dame |
| 12/06/2007 | US20070281966 Method for antagonizing MIF activity |
| 12/06/2007 | US20070281965 modulators of GABAA receptors comprising deuterated analogs of zolpidem, used for the treatment and management of sleep disorders, and/or for providing a patient in need with a hypnotic, anxiolytic or anticonvulsive effect |
| 12/06/2007 | US20070281964 Novel Crystalline Polymorphs of Clopidogrel |
| 12/06/2007 | US20070281963 tyrosine kinase inhibitors such as 3-amino-2-(2-chloro-5-hydroxyphenyl)-7-(3-morpholin-4-ylpropoxy)-2,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-one, used as anticarcinogenic or antiproliferative agents |
| 12/06/2007 | US20070281962 Administering 1,2,3,6-tetrasubstituted pyrido[3,4-b]indoles to inhibit the 5'-untranslated region-dependent translation; anticarcinogenic agents; retinopathy, rheumatoid arthritis, psoriasis, atherosclerosis, obesity, macular degeneration |
| 12/06/2007 | US20070281961 Modified Compositions And Methods For Enhancing Brain Function |
| 12/06/2007 | US20070281960 Anti-Histaminic Composition |
| 12/06/2007 | US20070281959 Glucocorticoid receptor modulator compounds and methods |
| 12/06/2007 | US20070281958 Preparation of oxycodone |
| 12/06/2007 | US20070281957 Crystalline Forms of Levorphanol |
| 12/06/2007 | US20070281956 Phenylpyrimidine amines as IgE inhibitors |
| 12/06/2007 | US20070281955 e.g. 3-{5-[2-({(3R)-1-[(4-chlorophenyl)sulfonyl]piperidin-3-yl}amino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl carbamate; antiproliferative, anticarcinogenic agent; cell proliferative disorders |
| 12/06/2007 | US20070281954 Cyclohexyl-1,4-diamine compounds |
| 12/06/2007 | US20070281953 Substituted Dihydroquinazolines II |
| 12/06/2007 | US20070281952 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists |
| 12/06/2007 | US20070281951 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 12/06/2007 | US20070281949 such as 3-(2-Cyclopentyl-2H-pyrazolo[3,4-d]pyrimidin-4-yl)-2-oxo-2,3-dihydro-1H-indole-5-carbonitrile, use in the treatment of neurodegenerative diseases, neurotraumatic diseases, depression and/or diabetes |
| 12/06/2007 | US20070281948 Substituted 2-pyridone derivatives, method for their preparation and their use as medicament |
| 12/06/2007 | US20070281947 Diarylmethylpiperazines As Prophylactic Or Therapeutic Agents For Viral Myocarditis |
| 12/06/2007 | US20070281946 Tri(cyclo) substituted amide compounds |
| 12/06/2007 | US20070281945 Benzoxazole and benzothiazole derivatives as 5-hydroxytryptamine-6 ligands |
| 12/06/2007 | US20070281944 Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 12/06/2007 | US20070281943 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 12/06/2007 | US20070281942 Glucokinase activators |
| 12/06/2007 | US20070281941 Dihydrogenphosphate salt of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3- alpha ]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine; diabetes, obesity, and high blood pressure |
| 12/06/2007 | US20070281940 Uses of dpp-iv inhibitors |
| 12/06/2007 | US20070281939 5-(3,5-Dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(1-hydroxy-cycloheptylmethyl)benzamide derivatives in which the triazine ring has various 4-substituents, e.g., carbamoylmethyl-, dimethylaminoethyl-, acetylaminoethyl-, and pyridinylmethyl-; treating rheumatoid arthritis |
| 12/06/2007 | US20070281938 Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1 |
| 12/06/2007 | US20070281937 Use of various imidazole compounds such as 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof to treat angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or nervous system disorders |
| 12/06/2007 | US20070281936 To reducte the purinergic neurotransmission; Parkinson's disease; dyskinesias; Movement disorders; Adenosine receptors antagonists; 2-Methylamino-6-(5-methyl-2-furyl)-N-(2-pyridylmethyl)pyrimidine-4-carboxamide |
| 12/06/2007 | US20070281935 Use |
| 12/06/2007 | US20070281934 Indole derivatives as inhibitors of histone deacetylase |
| 12/06/2007 | US20070281933 Novel Indazole Carboxamides And Their Use |
| 12/06/2007 | US20070281932 Method of preparing 4-halogenated quinoline intermediates |
| 12/06/2007 | US20070281931 Pharmaceutical Composition Containing a P2x7 Receptor Antagonist and Methotrexate |
| 12/06/2007 | US20070281928 Fused Ring Azadecalin Glucocorticoid Receptor Modulators |
| 12/06/2007 | US20070281927 Anti-inflammatory and analgesic compositions and related methods |
| 12/06/2007 | US20070281926 Rectal Composition |
| 12/06/2007 | US20070281925 Use of sertindole for the preventive treatment of suicidal behaviour |
| 12/06/2007 | US20070281924 MIF inhibitors for treating neuropathic pain and associated syndromes |
| 12/06/2007 | US20070281923 (4-Cyclopropyl-[1,4]diazepan-1-yl)-[6-(3,4-dichloro-phenoxy)-pyridin-3-yl]-methanone; (4-cyclobutyl-[1,4]diazepan-1-yl)-[6-(4-fluoro-phenoxy)-pyridin-3-yl]-methanone hydrochloride monohydrate; cognitive disorders, sleep disorders, psychiatric disorders |
| 12/06/2007 | US20070281922 1-Sulfonylindazolylamine and - amide derivatives as 5-hydroxytryptamine-6 ligands |
| 12/06/2007 | US20070281921 Piperidinyl pyrimidine derivatives |
| 12/06/2007 | US20070281920 5-(1H-indol-5-yl)-2-methyl-2,3,4,5-tetrahydro-1H-benzo[c]azepine; for treatment of monoamine reuptake inhibitor-mediated diseases such as depression, anxiety, genitourinary disorders and pain |
| 12/06/2007 | US20070281919 Aminothiazole Derivatives And Their Use As CRF Receptor Ligands |
| 12/06/2007 | US20070281918 Pyridoazepine derivatives |
| 12/06/2007 | US20070281917 HIV Integrase Inhibitors |
| 12/06/2007 | US20070281916 Substituted isoxazolines and their use as antibacterial agents |
| 12/06/2007 | US20070281915 Porphyrin Derivatives and Their Use in Photodynamic Therapy |
| 12/06/2007 | US20070281914 Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye |
| 12/06/2007 | US20070281913 Method for treating eye disease or conditions affecting the posterior segment of the eye |
| 12/06/2007 | US20070281912 treating with a mixture comprising nomegestrol acetate and estradiol valerate or estradiol; side effect reduction |
| 12/06/2007 | US20070281911 Use of Adefovir or Tenofovir for Inhibiting Mmtv-Like Viruses Involved in Breast Cancer and Primary Biliary Cirrhosis |
| 12/06/2007 | US20070281910 Salicyl alcohol creatine phosphate prodrugs, compositions and uses thereof |
| 12/06/2007 | US20070281909 Creatine phosphate prodrugs, compositions and uses thereof |
| 12/06/2007 | US20070281908 Composition and methods to treat cardiac diseases |
| 12/06/2007 | US20070281907 Kinase Inhibitor Phosphonate Conjugates |
| 12/06/2007 | US20070281906 Selective androgen receptor modulators for treating diabetes |
| 12/06/2007 | US20070281905 Use of simethicone in constipated patients |
| 12/06/2007 | US20070281904 Chitosan-derivative compounds and methods of controlling microbial populations |
| 12/06/2007 | US20070281903 Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX |
| 12/06/2007 | US20070281902 5-{6-[N'-(furan-2-carbonyl)-hydrazino]-9H-purin-9-yl}-3,4-dihydroxy-tetrahydrofuran-2-carboxylic acid ethylamide; septic shock; cystic fibrosis;sexual impotency; diarrhea; hyperplasia; hypotensive agents; arteriosclerosis; cardiovascular disorders; stress for imaging of ischemic coronary |
| 12/06/2007 | US20070281898 Vector |
| 12/06/2007 | US20070281897 By administering a cyclic di-GMP or a cyclic dinucleotide analogue; use as vaccine adjuvant |
| 12/06/2007 | US20070281895 Molecular Marker |
| 12/06/2007 | US20070281894 Preparation and utility of substituted erythromycin analogs |
| 12/06/2007 | US20070281893 Polysulfated Glycosides And Salts Thereof |
| 12/06/2007 | US20070281892 Dopaminergic Mimetics |
| 12/06/2007 | US20070281891 Lock solution for medical devices |
| 12/06/2007 | US20070281888 having an activity of growing vascular endothelial cells, promoting transcription form c-fos promoter, promoting transciption from VEGF promoter and/or an angiogenic activity; a polynucleotide encoding this polypeptide; for treating obstructive arteriosclerosis, peripheral vascular disorder, angina |
| 12/06/2007 | US20070281884 Macrocyclic oximyl hepatitis C protease inhibitors |
| 12/06/2007 | US20070281882 stimulating collagen synthesis and proteoglycan (lumican and keratocan) accumulation; Ethyl-3,4-dihydroxybenzoate (EDB) overrides the effects of ascorbate on pepsin resistance and proteoglycan accumulation |
| 12/06/2007 | US20070281881 Methods And Compositions Comprising Non-Peptide Small Molecules That Solubilize Beta Amyloid Peptide Fiber |
| 12/06/2007 | US20070281070 Sterilization Solution and Method for Manufacturing Sterilization Solution |
| 12/06/2007 | US20070281043 Microbicidal composition |
| 12/06/2007 | US20070281042 Combinations of chromium with antidiabetics for glucose metabolism disorders |
| 12/06/2007 | US20070281041 Compositions and Methods Involving MDA-7 for the Treatment of Cancer |
| 12/06/2007 | US20070281040 Combination therapy of hedgehog inhibitors, radiation and chemotherapeutic agents |
| 12/06/2007 | US20070281036 System and method of delivering a desired material to a cell |
| 12/06/2007 | US20070281034 Magnetic microparticles comprising organic substances |
| 12/06/2007 | US20070281030 Non-Lamellar Compositions of Dope and P80 |
| 12/06/2007 | US20070281028 Drug Delivery of a Cox Inhibitor from Embolic Agents |
| 12/06/2007 | US20070281027 Multilaminate backing construction |
| 12/06/2007 | US20070281026 Elastin stabilization of connective tissue |
| 12/06/2007 | US20070281025 Cholesterol-Interacting Layered Phyllosilicates and Methods of Reducing Hypercholesteremia in a Mammal |
| 12/06/2007 | US20070281023 Pharmaceutical composition for modified release insulin sensitiser |
| 12/06/2007 | US20070281021 Sustained release formulation of naltrexone |
| 12/06/2007 | US20070281020 Pharmaceutical compositions for sustained release of phenylephrine |
| 12/06/2007 | US20070281019 Phenylephrine pulsed release formulations and pharmaceutical compositions |
| 12/06/2007 | US20070281018 Sustained release formulations of opioid and nonopioid analgesics |
| 12/06/2007 | US20070281017 Sustained release oxycodone composition with acrylic polymer and metal hydroxide |
| 12/06/2007 | US20070281016 Sustained release oxycodone composition with acrylic polymer and surfactant |
| 12/06/2007 | US20070281015 Anti-acid pharmaceutical composition in powder form and process for making it |
| 12/06/2007 | US20070281011 Nanoparticulate posaconazole formulations |
| 12/06/2007 | US20070281010 Compositions And Methods For Enhancing Brain Function |
| 12/06/2007 | US20070281009 N-Acetylglucosamine Tablet Disintegrating In Oral Cavity And Process For Producing The Same |
| 12/06/2007 | US20070281008 Personal lubricant compositions and kits for providing personal lubrication |
| 12/06/2007 | US20070281007 Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs |